Brief: Biophytis Announces Ratio Change Under Its American Depositary Receipt Program
17/03/2023 07:09
March 17 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS ANNOUNCES RATIO CHANGE UNDER ITS AMERICAN
DEPOSITARY
RECEIPT (“ADR”) PROGRAM
Source text for Eikon: urn:newsml:reuters.com:*:nEQ9pwMN0a
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon